Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series.

Giovanni Di MauroGiovanni VietriLoreta QuarantaFabio PlacidiFrancesca IzziAlessandro CastelliAndrea PaganoFrancesca LeonardisViviana De AngelisCiro BiancoMaria Grazia CelesteNicola Biagio MercuriClaudio Liguori

Published in: CNS & neurological disorders drug targets (2024)

According to our experience, hpCBD should be taken into consideration as an add-on therapy of RSE and SRSE while also considering the possibility of maintaining this treatment during the follow-up of patients. However, more studies and real-world experiences are needed to better understand its effectiveness in this setting and the interaction with other ASMs.

Keyphrases

randomized controlled trial
end stage renal disease
systematic review
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
stem cells
combination therapy
smoking cessation